Outcomes of patients treated with the everolimus-eluting stent versus the zotarolimus-eluting stent in a consecutive cohort of patients at a tertiary medical center
Nicolas W Shammas, Gail A Shammas, Elie Nader, Michael Jerin, Luay Mrad, Peter Marogil, Courtney Henn, Alex Dvorak, Archana Chintalapani, Susan MerinerMidwest Cardiovascular Research Foundation, Davenport, IA, USABackground: In this study we compared the outcomes of the everolimus-eluting stent (EES...
Main Authors: | Jerin M, Mrad L, Marogil P, Henn C, Dvorak A, Chintalapani A, Meriner S, Nader E, Shammas GA, Shammas NW |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-04-01
|
Series: | Vascular Health and Risk Management |
Online Access: | http://www.dovepress.com/outcomes-of-patients-treated-with-the-everolimus-eluting-stent-versus--a9659 |
Similar Items
-
Sex differences in long-term outcomes of coronary patients treated with drug-eluting stents at a tertiary medical center
by: Shammas NW, et al.
Published: (2014-09-01) -
The Resolute Zotarolimus-eluting stent and diabetes mellitus
Published: (2012-11-01) -
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
by: Alev Arat Ozkan, et al.
Published: (2016-05-01) -
A meta-analysis of everolimus-eluting stents versus sirolimus-eluting stents and paclitaxel-eluting stents in diabetic patients
by: Hang Ouyang, et al.
Published: (2021-04-01) -
Everolimus-eluting coronary stents
by: Alejandro Saez, et al.
Published: (2010-09-01)